Lebwohl, M., Warren, R. B., Imafuku, S., Bagel, J., Armstrong, A. W., Passeron, T., Banerjee, S., Colombo, M. J., Scharnitz, T., Hoyt, K., Thaci, D., & Blauvelt, A. (2024). Deucravacitinib Long-Term Efficacy Through 4 years in Week 16 Placebo Crossover Patients in the Phase 3 POETYK PSO-1, PSO-2, and LTE Program. SKIN The Journal of Cutaneous Medicine, 8(4), s408. https://doi.org/10.25251/skin.8.supp.408